Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Another celebrity pitch from Shire

Executive Summary

After being cited by FDA for its promotion of Adderall XR (amphetamine salts) on YouTube, which featured celebrity carpenter Ty Pennington, the company launched a Web site featuring actor/comedian Howie Mandel aimed at promoting adult ADHD awareness. In the Adderall YouTube video, Pennington promotes the use of Adderall using voice inflection to emphasize words like "amazing" (1"The Pink Sheet," Oct. 6, 2008, p. 12). The new Web site is more of a public service campaign, with links to ADD and ADHD organizations, and nowhere mentions Adderall. The Adult ADHD Is Real campaign ( highlights the disease with Mandel's personal story. "I found it difficult to sit down and read a script for work, or even have a conversation - you know the kind when you're actually listening without interrupting?" he writes. Mandel is also the voice in three radio promotions and the subject of three television clips to increase adult ADHD awareness

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts